MedPath

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States
Ownership
-
Established
1896-01-01
Employees
-
Market Cap
-
Website
https://www.bidmc.org/

tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis

Not Applicable
Withdrawn
Conditions
Chronic Pancreatitis
Pain
Interventions
Device: tDCS
Behavioral: Meditation
First Posted Date
2013-05-20
Last Posted Date
2015-03-11
Lead Sponsor
Beth Israel Deaconess Medical Center
Registration Number
NCT01857492
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Physical Health in Midlife: Influences of Adversity and Relationships Over Time

Completed
Conditions
Cardiovascular Disease
Type 2 Diabetes
First Posted Date
2013-05-15
Last Posted Date
2017-07-24
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
210
Registration Number
NCT01853332
Locations
🇺🇸

Judge Baker Children's Center, Boston, Massachusetts, United States

Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease

Phase 1
Completed
Conditions
Crohn's Disease
Interventions
Biological: Fecal Microbial Transplantation
First Posted Date
2013-05-06
Last Posted Date
2017-03-03
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
22
Registration Number
NCT01847170
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

House Calls and Decision Support: Improving Access to Live Donor Transplantation

Not Applicable
Completed
Conditions
Chronic Kidney Disease
End-Stage Renal Disease
Interventions
Behavioral: House Calls
Behavioral: Web-Based Patient-Centered Decision Support Intervention
First Posted Date
2013-02-08
Last Posted Date
2020-07-15
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
109
Registration Number
NCT01786525
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss

Not Applicable
Completed
Conditions
Weight Loss
Obesity
Interventions
Dietary Supplement: Weight loss group (Full meal replacement products)
First Posted Date
2013-01-31
Last Posted Date
2017-08-07
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
5
Registration Number
NCT01780870
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Lenalidomide After Allo Transplant

Phase 1
Terminated
Conditions
Multiple Myeloma
Lymphoma
Interventions
First Posted Date
2012-12-17
Last Posted Date
2017-04-18
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
1
Registration Number
NCT01750762
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Soy Nuts and Cardiovascular Risk in Postmenopausal Women

Not Applicable
Completed
Conditions
Postmenopausal Women
Interventions
Other: soy nuts
First Posted Date
2012-12-04
Last Posted Date
2025-05-22
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
84
Registration Number
NCT01740076
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States

Early Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-11-07
Last Posted Date
2020-10-12
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
38
Registration Number
NCT01722669
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS

Not Applicable
Completed
Conditions
HMG COA Reductase Inhibitor Adverse Reaction
Myopathy
Hypercholesterolemia
Interventions
Dietary Supplement: placebo
Dietary Supplement: ubiquinol
First Posted Date
2012-10-10
Last Posted Date
2017-04-17
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
22
Registration Number
NCT01702987
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures

Not Applicable
Completed
Conditions
Acute Respiratory Distress Syndrome
Interventions
Other: Esophageal-pressure guided mechanical ventilation
Other: High PEEP mechanical ventilation
First Posted Date
2012-09-07
Last Posted Date
2019-12-03
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
202
Registration Number
NCT01681225
Locations
🇺🇸

University of California at San Diego, La Jolla, California, United States

🇺🇸

Stanford University Medical Center, Stanford, California, United States

🇺🇸

Orlando Health, Orlando, Florida, United States

and more 11 locations
© Copyright 2025. All Rights Reserved by MedPath